Summary.-Breast-cancer tissue from 60 patients was tested for oestrogen and testosterone sensitivity in vitro by measuring [3H]-dT incorporation in tissue fragments at various times during 48h culture. Hormone sensitivity in test culture was determined as an increase or decrease in dT uptake. In vitro cultures of breastcancer tissue demonstrate that some tumours are hormone-sensitive and others hormone-insensitive, but it cannot be predicted whether cell proliferation is stimulated or inhibited by hormone treatment.
ONE THIRD OF PATIENTS with advanced breast cancer respond to endocrine therapy.
The oestrogen-receptor (RE) assay on breast-cancer tissue has been used to select patients for hormonal treatment, but as present only half the patients with RE+ tumours actually benefit from endocrine therapy. It has been shown, however, that tumours containing both RE and progesterone receptors, and tumours containing high RE levels, are more likely to respond (70-80%) than tumours with low RE levels or none (5-10%; McGuire, 1980) . Instead of measuring the initial binding step in the hormone action, another approach would be to determine hormonal influence on the tumours in vitro. It has been shown that the in vitro effect of hormones on breast-cancer tissue is not simply a reflection of the presence or absence of steroid receptors (Israel & Saez, 1978; Poulsen, 1978; Sanfillipo et al., 1979) and our proposed line of investigation might yield new information.
The purpose of this study was to observe the effect of various hormones on the [3H]-dT incorporation in breast-cancer tissue in vitro, and to compare the results with the effect of hormonal treatment on patients with advanced breast cancer. from 60 patients with primary breast cancer were placed in ice-cold Eagle's minimal essential medium (MEM) and prepared for cultivation within 1 h ofremoval. All damaged and fatty tissue was removed, and the rest was minced into small fragments ( -0 5 mm3) with a pair of scissors, all under sterile conditions. With a spatula, [15] [16] [17] [18] [19] [20] fragments were then randomly transferred to 10 ml test tubes containing 5 ml culture medium and allowed to float freely. The medium was MEM with added antibiotics (100 iu/ml of penicillin and 100 ,ug/ml streptomycin) and supplemented with foetal calf serum to a concentration of 5%. Four cultures of 15-20 fragments each were set up for each hormone and for control. All cultures were grown in an atmosphere of 95% humidified air and 5% C02 at 370C. The tissue fragments were cultivated under the following conditions;
MATERIALS AND METHODS

In
(1) controls, 0.1% ethanol added, (2) 17-poestradiol, 1 juM, (3) testosterone, 1 ,aM.
The steroid hormones were dissolved in ethanol, of which the final concentration was 0-1% of the total volume in the culture medium. They were added to the medium when the cultures were set up.
At different times after explantation, [3H]-dT was added to the cultures for 1 h (2.5 ,uCi/ml, 2X0 Ci/mmol) and the incorporation was terminated by placing the cultures on ice. The supernatant was removed and 5% trichloroacetic acid added for 45 min. After centrifugation (800 g, 40C) for 10 min, the final sediment was dissolved in 2-0 ml 1 M NaOH for 2 h at 60°C. Each sample was divided into two portions. One portion (200 ,ld) was prepared for scintillation counting by mixing it with 12 ml scintillation fluid (Insta-gel). Radioactivity was measured in a Packard TriCarb 3003 spectrophotometer. The quench was checked with channel radio correction. The other portion (100 jAl) was prepared for protein measurement by the method of Lowry.
The results were expressed in terms of ct/min/,ug protein.
As the results may not be normally distributed, the results of controls and hormone-treated cultures were compared by means of the nonparametric Mann-Whitney test (Diem & Lentner, 1970 
RESULTS
Histological and autoradiographic studies The biopsy specimens received were all confirmed as breast cancer. Examination of the cultivated fragments showed that the tissue was well preserved. In general, necrobiosis was only slightly accentuated during cultivation.
In most of the autoradiographs, the background radiation was negligible. The radioactivity was localized in the cell nuclei. Apart from a few fibroblasts, all labelled cells were epithelial. Cells with pyknotic nuclei did not incorporate thymidine.
Thymidine incorporation in cultures at varying times after explantation Preliminary experiments were carried out to determine culture conditions, and to determine whether specimens from the same tumour showed comparable uptake of [3H]-dT under the same conditions. It was found in 4 tumours that samples consisting of 4 cultures of 15-20 fragments each were comparable, whether protein or DNA content was used (Bonting & Jones, 1957) .,!-"., .;:..,.,-:
-,,-.-, , , --r -1..,. .;
1,"-... The infiltrating-duct carcinomas were graded according to the method described by Scharff & Torloni (1968) and, as seen from not followed up properly with X-ray and clinical examinations. In total, 5 patients out of 28 were excluded. Two patients had 2 cancers, and in 3 cases the follow-up was not evaluable. The clinical trial was retrospective. The patients were not given a specific hormonal treatment based on a protocol, but neither were the treatments influenced by the results of the in vitro hormonal sensitivity investigations. The criteria for clinical response were defined as follows:
(1) CR-complete remission: total disappearance of measurable disease.
(2) PR-partial remission: 50-99o reduction of measurable disease and/or recalcification of osteolytic metastases. No lesions showed progression and there were no new lesions.
(3) SD-stationary disease: <50o reduction in measurable tumour mass and/or no change in osteolytic bone metastases.
(4) PD-progression of measurable tumour mass and/or appearance of new lesions. Metastases showed no regression. The duration of response was defined as the time from initial treatment to progressive disease.
The characteristics of the patients are shown in Table V . It can be seen that several hormonal treatments have been used. Premenopausal women were always castrated by X-ray, which was occasionally supplemented with other forms of hormonal treatment (Pts 10, 15, 19, 20 & 23 (Table V) . The median disease-free interval in responders was 27-5 months (range 12-46) and in non-responders 18 months (range 0-52).
DISCUSSION
Over the years a number of publications have presented data in terms of in vitro response to hormones and chemotherapy of human solid tumours. Different methods have been applied, and advantages as well as disadvantages in these methods have been extensively discussed (Dendy, 1980; Hodges, 1976; Lasfarques, 1975; Masters et al., 1980) and will not be discussed further in the present paper. (340) 187 (26) 419 (125) 315 (11)* 254 (68) 365 (33) 227 (48) 172 (43) 101 (16) 151 (55) 338 (39) 217 (33)*
175 (62) 159 (72) 198 (130) 118 (36) 129 (72) 137 (87) (Aspegren & Danielsson, 1974; Finkelstein et al., 1975; Pasteels et al., 1976) . If this were so, the (Aspegren, 1974; Aspegren & Danielsson, 1974; Burstein & Carey, 1974; . Whether the optimal time to test the dT uptake is > 24 h after explantation is not possible to conclude from the present study. Other tumours might possibly have shown hormonal sensitivity in vitro at other times. However, whenever a significant difference in dT uptake was seen in hormone-treated cultures, compared to controls, in the 7 tumours tested at different times, it was consistently recorded after 24 h of culture.
Though the number of patients is limited in this study, and the trial was retrospective, the observed significant correlation between the response to hormonal treatment in patients with advanced breast cancer and the in vitro hormonal sensitivity of the corresponding tumours is of interest. It should be emphasized, however, that only half of the patients who were expected to respond on the basis of the in vitro test actually responded to endocrine therapy. On the other hand, only one patient responded to endocrine therapy in the in vitro hormoneinsensitive group. Thus this study agrees with the results of Burstein & Carey (1974) , who found that 17/23 patients with advanced breast cancer correlated with the hormonal response in vitro. Our study is also consistent with another study (Dendy, 1980) in which in vitro methods were helpful in selecting patients who were chemotherapy-resistant.
One other group (Flax et al., 1973; Salih, 1972) has previously published that the influence of hormones in vitro on breastcancer tissue, as measured by influence on glucose-6-phosphate dehydrogenase activity, was correlated with the clinical response in patients with advanced breast cancer. However, it should be pointed out that their method has never been reproduced (Masters et al., 1977) .
In conclusion the present test does, to some extent, reflect the in vivo hormonal dependence of some breast tumours. The test, however, cannot be used alone to predict patients' response to hormonal therapy, but it is possible that this test, in combination with steroid-receptor determinations, could more precisely predict which patients with advanced breast cancer might benefit from hormonal treatment. This remains to be shown in a prospective controlled trial.
